|
1
|
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
5.34
|
|
2
|
Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.
|
Hepatology
|
2014
|
3.06
|
|
3
|
Prospective study of hyperglycemia and cancer risk.
|
Diabetes Care
|
2007
|
2.89
|
|
4
|
Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study.
|
J Natl Cancer Inst
|
2011
|
2.63
|
|
5
|
Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies.
|
Int J Cancer
|
2002
|
2.60
|
|
6
|
Obesity and colon cancer: does leptin provide a link?
|
Int J Cancer
|
2004
|
1.89
|
|
7
|
The effects of storage time and sampling season on the stability of serum 25-hydroxy vitamin D and androstenedione.
|
Nutr Cancer
|
2010
|
1.86
|
|
8
|
Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts.
|
PLoS Med
|
2009
|
1.83
|
|
9
|
Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.77
|
|
10
|
Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.
|
J Clin Endocrinol Metab
|
2006
|
1.71
|
|
11
|
Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study.
|
J Clin Oncol
|
2012
|
1.70
|
|
12
|
Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.67
|
|
13
|
Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
Endocr Relat Cancer
|
2008
|
1.65
|
|
14
|
Biomarkers of oxidative stress and risk of developing colorectal cancer: a cohort-nested case-control study in the European Prospective Investigation Into Cancer and Nutrition.
|
Am J Epidemiol
|
2012
|
1.65
|
|
15
|
Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition.
|
Cancer Causes Control
|
2007
|
1.48
|
|
16
|
Circulating inflammation markers and risk of epithelial ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.44
|
|
17
|
Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort.
|
Int J Cancer
|
2006
|
1.43
|
|
18
|
Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.37
|
|
19
|
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
|
Breast Cancer Res
|
2012
|
1.37
|
|
20
|
Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study.
|
Endocr Relat Cancer
|
2010
|
1.35
|
|
21
|
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
|
Int J Cancer
|
2011
|
1.31
|
|
22
|
Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition.
|
Int J Cancer
|
2010
|
1.28
|
|
23
|
Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study.
|
Int J Cancer
|
2012
|
1.23
|
|
24
|
Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.
|
Cancer Prev Res (Phila)
|
2011
|
1.23
|
|
25
|
Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study.
|
Int J Cancer
|
2011
|
1.22
|
|
26
|
Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden.
|
Int J Cancer
|
2007
|
1.21
|
|
27
|
Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.20
|
|
28
|
The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study.
|
Breast Cancer Res Treat
|
2008
|
1.19
|
|
29
|
Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.16
|
|
30
|
Fruits and vegetables and lung cancer: Findings from the European Prospective Investigation into Cancer and Nutrition.
|
Int J Cancer
|
2004
|
1.16
|
|
31
|
Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort.
|
Int J Cancer
|
2012
|
1.15
|
|
32
|
Metabolic syndrome and risks of colon and rectal cancer: the European prospective investigation into cancer and nutrition study.
|
Cancer Prev Res (Phila)
|
2011
|
1.15
|
|
33
|
Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
Endocr Relat Cancer
|
2007
|
1.12
|
|
34
|
Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).
|
Gynecol Oncol
|
2012
|
1.11
|
|
35
|
Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
Carcinogenesis
|
2008
|
1.10
|
|
36
|
Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer.
|
Cancer Lett
|
2008
|
1.09
|
|
37
|
Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.
|
BMC Cancer
|
2013
|
1.05
|
|
38
|
Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.04
|
|
39
|
Postmenopausal sex hormones in relation to body fat distribution.
|
Obesity (Silver Spring)
|
2012
|
1.03
|
|
40
|
Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
Endocr Relat Cancer
|
2007
|
1.02
|
|
41
|
Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study.
|
Carcinogenesis
|
2012
|
1.02
|
|
42
|
Tumor necrosis factor (TNF)-α, soluble TNF receptors and endometrial cancer risk: the EPIC study.
|
Int J Cancer
|
2011
|
1.01
|
|
43
|
Determinants of maternal sex steroids during the first half of pregnancy.
|
Obstet Gynecol
|
2011
|
1.01
|
|
44
|
Effects of weight control and physical activity in cancer prevention: role of endogenous hormone metabolism.
|
Ann N Y Acad Sci
|
2002
|
1.01
|
|
45
|
Physical activity and ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.00
|
|
46
|
C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy).
|
Cancer Causes Control
|
2009
|
0.99
|
|
47
|
Metabolic syndrome and endometrial carcinoma.
|
Am J Epidemiol
|
2010
|
0.99
|
|
48
|
Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can).
|
Cancer
|
2010
|
0.99
|
|
49
|
Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.
|
Int J Cancer
|
2013
|
0.99
|
|
50
|
Fruit and vegetable consumption and risk of epithelial ovarian cancer: the European Prospective Investigation into Cancer and Nutrition.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.98
|
|
51
|
Reliability of follicle-stimulating hormone measurements in serum.
|
Reprod Biol Endocrinol
|
2003
|
0.98
|
|
52
|
A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study.
|
Ann Epidemiol
|
2006
|
0.97
|
|
53
|
Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: a prospective nested case-control study.
|
Eur J Cancer
|
2010
|
0.95
|
|
54
|
Insulin-like growth factor II and colorectal cancer risk in women.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
0.95
|
|
55
|
Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status-A prospective study within the EPIC cohort.
|
Int J Cancer
|
2013
|
0.95
|
|
56
|
Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort.
|
Int J Cancer
|
2014
|
0.94
|
|
57
|
Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis.
|
Am J Epidemiol
|
2013
|
0.94
|
|
58
|
Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study.
|
Int J Cancer
|
2013
|
0.94
|
|
59
|
Prospective study on physical activity and risk of in situ breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.93
|
|
60
|
Effect of long-term storage on hormone measurements in samples from pregnant women: the experience of the Finnish Maternity Cohort.
|
Acta Oncol
|
2007
|
0.93
|
|
61
|
Dietary total antioxidant capacity and gastric cancer risk in the European prospective investigation into cancer and nutrition study.
|
Int J Cancer
|
2012
|
0.92
|
|
62
|
IGF-I during primiparous pregnancy and maternal risk of breast cancer.
|
Breast Cancer Res Treat
|
2009
|
0.92
|
|
63
|
Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project.
|
Int J Epidemiol
|
2011
|
0.92
|
|
64
|
Leptin and soluble leptin receptor in risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohort.
|
Cancer Res
|
2012
|
0.92
|
|
65
|
Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study.
|
Int J Cancer
|
2012
|
0.92
|
|
66
|
Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.92
|
|
67
|
Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.
|
Cancer Epidemiol
|
2012
|
0.92
|
|
68
|
Physical activity and risk of breast cancer overall and by hormone receptor status: the European prospective investigation into cancer and nutrition.
|
Int J Cancer
|
2012
|
0.90
|
|
69
|
Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study.
|
J Natl Cancer Inst
|
2014
|
0.90
|
|
70
|
Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort.
|
Int J Cancer
|
2014
|
0.89
|
|
71
|
Dietary fiber intake and risk of hormonal receptor-defined breast cancer in the European Prospective Investigation into Cancer and Nutrition study.
|
Am J Clin Nutr
|
2012
|
0.89
|
|
72
|
Serum 25-hydroxyvitamin D at pregnancy and risk of breast cancer in a prospective study.
|
Eur J Cancer
|
2010
|
0.89
|
|
73
|
Consumption of meat and fish and risk of lung cancer: results from the European Prospective Investigation into Cancer and Nutrition.
|
Cancer Causes Control
|
2011
|
0.89
|
|
74
|
Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition.
|
Cancer Causes Control
|
2011
|
0.89
|
|
75
|
Factors associated with inflammation markers, a cross-sectional analysis.
|
Cytokine
|
2011
|
0.89
|
|
76
|
Biomarker patterns of inflammatory and metabolic pathways are associated with risk of colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
Eur J Epidemiol
|
2014
|
0.89
|
|
77
|
The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Cohort.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.88
|
|
78
|
Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition.
|
Int J Cancer
|
2014
|
0.88
|
|
79
|
Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.88
|
|
80
|
Endogenous steroid hormone levels in early pregnancy and risk of testicular cancer in the offspring: a nested case-referent study.
|
Int J Cancer
|
2009
|
0.88
|
|
81
|
Dietary flavonoid, lignan and antioxidant capacity and risk of hepatocellular carcinoma in the European prospective investigation into cancer and nutrition study.
|
Int J Cancer
|
2013
|
0.88
|
|
82
|
IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies.
|
Eur J Cancer Prev
|
2005
|
0.87
|
|
83
|
Circulating vitamin d and risk of epithelial ovarian cancer.
|
J Oncol
|
2009
|
0.87
|
|
84
|
Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort.
|
Int J Cancer
|
2012
|
0.87
|
|
85
|
Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer.
|
Cancer Res
|
2010
|
0.86
|
|
86
|
Coffee and tea consumption and the risk of ovarian cancer: a prospective cohort study and updated meta-analysis.
|
Am J Clin Nutr
|
2012
|
0.86
|
|
87
|
Dietary intake of heme iron and risk of gastric cancer in the European prospective investigation into cancer and nutrition study.
|
Int J Cancer
|
2011
|
0.85
|
|
88
|
Dietary flavonoid intake and esophageal cancer risk in the European prospective investigation into cancer and nutrition cohort.
|
Am J Epidemiol
|
2013
|
0.84
|
|
89
|
Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
0.83
|
|
90
|
Serum 25-hydroxyvitamin D and the risk of ovarian cancer.
|
Eur J Cancer
|
2009
|
0.83
|
|
91
|
Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.82
|
|
92
|
Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.
|
Breast Cancer Res Treat
|
2013
|
0.82
|
|
93
|
Maternal hormones during early pregnancy: a cross-sectional study.
|
Cancer Causes Control
|
2010
|
0.82
|
|
94
|
Adiposity, mediating biomarkers and risk of colon cancer in the European prospective investigation into cancer and nutrition study.
|
Int J Cancer
|
2013
|
0.82
|
|
95
|
Weight change later in life and colon and rectal cancer risk in participants in the EPIC-PANACEA study.
|
Am J Clin Nutr
|
2013
|
0.82
|
|
96
|
Coffee and tea intake and risk of brain tumors in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study.
|
Am J Clin Nutr
|
2010
|
0.82
|
|
97
|
HbA1c measured in stored erythrocytes is positively linearly associated with mortality in individuals with diabetes mellitus.
|
PLoS One
|
2012
|
0.82
|
|
98
|
Circulating prolactin levels and risk of epithelial ovarian cancer.
|
Cancer Causes Control
|
2013
|
0.81
|
|
99
|
Does pregnancy or pregnancy loss increase later maternal risk of diabetes?
|
Eur J Epidemiol
|
2012
|
0.81
|
|
100
|
Dairy products and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition.
|
Int J Cancer
|
2014
|
0.81
|
|
101
|
Circulating enterolactone and risk of endometrial cancer.
|
Int J Cancer
|
2006
|
0.80
|
|
102
|
Alcohol drinking and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
|
Ann Epidemiol
|
2012
|
0.80
|
|
103
|
Multiple miscarriages are associated with the risk of ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition.
|
PLoS One
|
2012
|
0.78
|
|
104
|
Free β-human chorionic gonadotropin, total human chorionic gonadotropin and maternal risk of breast cancer.
|
Future Oncol
|
2014
|
0.78
|
|
105
|
The challenge of measuring circulating estradiol at low concentrations.
|
Breast Cancer Res
|
2005
|
0.76
|
|
106
|
Circulating insulin-like growth factor-I in pregnancy and maternal risk of breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.76
|
|
107
|
Association of serum 25-hydroxyvitamin D (25-OHD) concentrations with maternal sex steroids and IGF-1 hormones during pregnancy.
|
Cancer Causes Control
|
2011
|
0.76
|
|
108
|
Circulating soluble Fas levels and risk of ovarian cancer.
|
BMC Cancer
|
2003
|
0.75
|
|
109
|
Insulin-like growth factor-I and C-reactive protein during pregnancy and maternal risk of non-epithelial ovarian cancer: a nested case-control study.
|
Cancer Causes Control
|
2011
|
0.75
|
|
110
|
Fetal Down syndrome and the risk of maternal breast cancer.
|
Epidemiology
|
2009
|
0.75
|